DNA vaccination with CD44 variant isoform reduces mammary tumor local growth and lung metastasis.
We have shown recently that cDNA vaccination, using a virtual lymph node, ameliorates experimental allergic encephalomyelitis. Successful cure from mammary tumor requires resolution of local tumor growth and metastases. We have examined whether targeting of CD44 cell surface adhesion molecule by cDNA vaccination plays a role in resolving mammary tumor development. We show here that CD44 cDNA vaccination decreases the tumor mass and metastatic potential in experimental mammary tumor of BALB/c mice. Vaccination of mice, inoculated with the mammary tumors, by cDNA of CD44 variant (CD44v) but not by cDNA of standard CD44, markedly reduced local tumor development and lung metastasis. Concomitantly, transfection of CD44 antisense into a highly metastatic mammary tumor cell line disrupted the CD44 expression of the cells and reduced their ability to establish local tumors as well as metastatic colonies in the lung. Moreover, when CD44v, but not standard CD44 sense cDNA, was transfected into the poorly metastatic cell line, tumor development was markedly enhanced. It is possible therefore that DNA vaccination with a specific CD44v construct could induce an immune resistance to mammary tumor progression.
Wallach-Dayan
Shulamit Batya
SB
The Lung Cellular and Molecular Biology Laboratory, Institute of Pulmonary Medicine, The Hebrew University-Hadassah Medical School, P.O. Box 12000, Jerusalem, Israel. Wallach-Dayan@hadassah.org.il
Rubinstein
Ariel M
AM
Hand
Carla
C
Breuer
Raphael
R
Naor
David
D
D000818:Animals; D000912:Antibodies, Neoplasm / Q000276:immunology; D049109:Cell Proliferation; D002999:Clone Cells; D000939:Epitopes; D005260:Female; D006801:Humans; D018960:Hyaluronan Receptors / Q000276:immunology*; D008175:Lung Neoplasms / Q000276:immunology / Q000556:secondary*; D008198:Lymph Nodes / Q000276:immunology; D008325:Mammary Neoplasms, Experimental / Q000276:immunology / Q000473:pathology* / Q000628:therapy*; D051379:Mice; D008807:Mice, Inbred BALB C; D010641:Phenotype; D020033:Protein Isoforms / Q000276:immunology; D014162:Transfection; D014407:Tumor Cells, Cultured; D014611:Vaccination; D019444:Vaccines, DNA / Q000627:therapeutic use*
D000912:Antibodies, Neoplasm; D000939:Epitopes; D018960:Hyaluronan Receptors; D020033:Protein Isoforms; D019444:Vaccines, DNA